Tech Stock News
Thursday, January 26, 2023
Khosla Ventures Acquisition II Co (NASDAQ: KVSB) is under legal investigation. Law firm Brodsky & Smith announces that it has initiated an Investigation of Khosla Ventures Acquisition Co. II. Claims that are made against the company’s board of directors are under scrutiny. It is alleged that the board of directors […]
Provention Bio Inc (NASDAQ: PRVB) recently announced the receipt of a Complete Response Letter (CRL) from the USFDA regarding its Teplizumab’s Biologics License Application. Teplizumab is the company’s lead portfolio candidate anticipated to delay the progression of clinical Type-1 Diabetes in individuals at risk. However, the CRL didn’t mention any […]